Avoid common mistakes on your manuscript.
Dear Editor, we would like to share ideas on “Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination [1]” Aydoan et al. discovered that vaccine-induced autoimmune diabetes may be the cause of acute impairment of glucose regulation in a patient after BNT162b2 treatment [1]. Despite the likelihood of side effects from the COVID-19 immunization, clinical medicine places a lot of focus on the COVID-19 vaccine’s clinical impact on other systems. The current report may or may not constitute an adverse reaction to a vaccination. The recipient’s immune, endocrinological, or physical health pre-vaccination records are not readily available. It is difficult to make a clear, firm decision regarding the clinical relationship between vaccination and type 1 diabetes. A person who has received vaccines could possibly be comorbid. Additionally, the vaccine recipient could get a different illness. Clinical dengue infection can also occur after receiving the COVID-19 vaccination [2]. For instance, dengue illness can cause and co-occur with type 1 diabetes [3].
References
B.İ. Aydoğan, U. Ünlütürk, M. Cesur, Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine (2022). https://doi.org/10.1007/s12020-022-03130-8
A. Kebayoon, V. Wiwanitkit, Dengue after COVID-19 vaccination: possible and might be missed. Clin. Appl. Thromb. Hemost. 27, 10760296211047229 (2021)
V. Thadchanamoorthy, K. Dayasiri, A case report of dengue hemorrhagic fever complicated with diabetic ketoacidosis in a child: challenges in clinical management. BMC Pediatr. 20(1), 403 (2020). https://doi.org/10.1186/s12887-020-02300-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mungmunpuntipantip, R., Wiwanitkit, V. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine 78, 641 (2022). https://doi.org/10.1007/s12020-022-03169-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03169-7